Skip to main content

Popular anti-inflammatory drugs for joints have been shown in studies to harm patients

 Over 500 million people worldwide suffer from osteoarthritis. In this condition, nonsteroidal anti-inflammatory drugs with analgesic effects are traditionally used to treat pain. According to scientists from the University of California, San Francisco, their long-term consumption has an adverse effect on the progression of this disease.

 Osteoarthritis is one of the most common types of arthritis, affecting millions of people around the world. It can affect any joint, but the hips, knees, and fingers are the most commonly affected. Everyone's disease progresses differently.

Effects of NSAIDs and osteoarthritis

Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to treat joint pain in people with osteoarthritis. They provide relief in many cases, but according to researchers at the University of California, San Francisco, they can aggravate joint inflammation. Little is known about their long-term impact on disease progression at this time. This issue is still being debated by experts all over the world.

A panel of experts raised this issue at the Radiological Society of North America meeting (RSNA). Dr. hab. Johanna Luitjens of the University of California, San Francisco delivered the speech. She emphasized in her statement that "so far, no therapy has been approved that would cure or slow the progression of knee osteoarthritis."

The expert and her research team decided to conduct an investigation into the relationship between the use of NSAIDs and synovitis in osteoarthritic patients. Researchers wanted to see how NSAID treatment affects the development or progression of synovitis as well as cartilage imaging biomarkers.

The study included 277 people with moderate to severe osteoarthritis who had been taking NSAIDs for at least a year. The control group included 793 people who did not take nonsteroidal anti-inflammatory drugs. Each volunteer was subjected to magnetic resonance imaging at the start and end of the experiment (3T MRI). Researchers looked for biomarkers of inflammation in these images.

Unknown side effects of NSAID drugs have been discovered.

Based on the findings, it was determined that the use of NSAIDs in osteoarthritis provides no long-term benefit. Participants who took nonsteroidal anti-inflammatory drugs fared significantly worse on arthritis and cartilage quality indices. They were pitted against a control group.

With this analysis, the researchers were able to show that there are no protective mechanisms of NSAIDs when it comes to reducing inflammation or slowing the progression of knee osteoarthritis. According to Dr. Luitjens, 'The use of NSAIDs for their anti-inflammatory effects has been frequently promoted in OA patients in recent years and should be reconsidered as a positive effect on arthritis could not be demonstrated.'

The expert believes that prospective randomized trials should be conducted in the near future to provide conclusive evidence of the anti-inflammatory effects of NSAIDs

 

Labels:
Location: 81825 München, Deutschland

Comments

Post a Comment

Popular posts from this blog

Flying Just Got a Lot More Expensive — and Tariffs Are Only the Beginning

 As trade tensions escalate between major economies, new tariff uncertainties are weighing heavily on airlines. The consequences will ripple far beyond boardrooms and airfields: travelers should expect higher ticket prices, fewer route options, and a possible reshaping of the global aviation landscape. Immediate Impacts: Airlines Navigate a New Set of Risks In the short term, airlines are grappling with a complex mix of operational challenges: First, the aircraft supply chain is under pressure. Trade disputes between the United States, the European Union, and China have complicated the procurement of new planes. Manufacturers like Boeing, Airbus, and China's state-backed COMAC are caught in the middle, creating delays and pricing uncertainty for carriers ( Reuters ). Fuel markets are similarly volatile. Airlines typically hedge fuel prices months in advance to avoid sudden cost spikes. However, unpredictable shifts in global oil prices—driven in part by trade instability—are u...
Post a Comment
Read more

What’s it like to grow up in Vienna, Austria? | Young and European

Key Themes and Insights: City Overview 🏙️ Vienna is often referred to as the 'City of Music' and has consistently been voted the world's most livable city. ✨ The city balances open-mindedness with rich traditions, offering impressive infrastructure and educational opportunities. Living Environment 🏡 Sebi enjoys living in the eighth district, Josefstadt, known for its proximity to the city center but high rental prices. 💰 The average rent in Vienna is €9.80 per square meter, making it relatively affordable compared to other European cities, although this district is an exception. Education System 📚 Sebi attends one of the oldest schools in Vienna, where he studies multiple languages and engages in higher education preparation. 🎓 The average age for Austrians to move out is 25.5 years, with many students like Sebi aspiring to continue their education at nearby universities, such as the University of Vienna. Transportation 🚉 Vienna has an excellent public transport syste...
Post a Comment
Read more

Why U.S. Tech Giants Are Betting Big on Canadian AI?

  Why U.S. Tech Giants Are Betting Big on Canadian AI Imagine this: the most powerful tech companies in the world—Google, Meta, Microsoft—are betting their futures not just in Silicon Valley, but thousands of miles north, in the snowy cities of Canada. Strange, right? Why would billion-dollar U.S. tech giants rely so heavily on Canadian AI labs? What do Canadian researchers have that the tech capitals of California don’t? And could this quiet dependence shift the global tech balance? Let’s dive into a story of brainpower, policy, and a silent AI revolution that began long before most of us even knew what AI was. The Roots of Canada's AI Advantage To understand why U.S. tech titans are now so deeply entwined with Canada’s AI ecosystem, we need to go back to the early days of AI research—in the 1980s and '90s. At that time, the initial hype around artificial intelligence had faded. Funding was drying up globally, and many dismissed AI, especially deep learning, as a dead en...
Post a Comment
Read more